Caris Life Sciences Introduces Innovative PTEN IHC Testing for Precision Oncology in Prostate Cancer#United_States#Caris_Life_Sciences#Irving#Prostate_Cancer#PTEN_IHC_Testing
Caris Life Sciences Introduces Innovative PTEN IHC Testing for Precision Oncology in Prostate Cancer
Caris Life Sciences has unveiled PTEN IHC testing following FDA approval, enhancing precision oncology in metastatic prostate cancer management.
third-news.com
July 14, 2026 at 12:46 PM
Caris Life Sciences Introduces Innovative PTEN IHC Testing for Precision Oncology in Prostate Cancer#United_States#Caris_Life_Sciences#Irving#Prostate_Cancer#PTEN_IHC_Testing